Botulinum Toxin as a Treatment for Depression in a Real-world Setting.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

A series of randomized controlled trials have shown the efficacy of glabellar botulinum toxin (BTX) injection as a treatment for depression in women. We wanted to extend these findings and assess how they may be translated to a real-world setting.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Psychiatr Pract

Title: Journal of psychiatric practice

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1538-1145

ISSN (Print): 1527-4160

Publication date (Electronic): Jan 2018

Volume: 24

Issue: 1

Affiliations

[1 ] CHUGH: Neuropsychiatrist, Private Consultancy Practice, New Delhi, India CHHABRIA: Psychiatrist in Private Practice, Mumbai, India JUNG: Department of Psychiatry, Social Psychiatry and Psychotherapy, Medical School Hannover, Germany, and Asklepios Clinic North-Ochsenzoll, Asklepios Campus Hamburg, Medical Faculty, Semmelweis University, Germany KRUGER: Department of Psychiatry, Social Psychiatry and Psychotherapy, Medical School Hannover, Germany WOLLMER: Asklepios Clinic North-Ochsenzoll, Asklepios Campus Hamburg, Medical Faculty, Semmelweis University, Germany.

Article

Publisher Item ID: 00131746-201801000-00003

DOI: 10.1097/PRA.0000000000000277

PubMed ID: 29320379

SO-VID: 1b937ab3-c352-4108-9fe1-841ca06cae4c

History

Data availability:

Comments

Comment on this article

scite_

Cited by 14

See all cited by